The discovery and development of species-selective Hsp90 inhibitors capable of potentiating current antifungals in this unique way could make it possible to test this fundamental hypothesis in patients and help combat the growing threat of invasive fungal infection. The gene discussed is HSP90AA1; the disease is fungal infectious disease.